Hao Bo
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 17
- Circular RNAs in diseases 12
- RNA Research and Splicing 5
- Epigenetics and DNA Methylation 4
-
- Cancer-related molecular mechanisms research 30
- MicroRNA in disease regulation 7
- Co-authors
- Zhaojian Gong (8 shared papers)Guiyuan Li (6 shared papers)Zhaoyang Zeng (5 shared papers)Xiayu Li (5 shared papers)Wei Xiong (6 shared papers)Ming Zhou (5 shared papers)Wenling Zhang (4 shared papers)Bo Xiang (5 shared papers)
- Journals
- Journal of Cancer (6 papers)Oncogene (3 papers)Frontiers in Endocrinology (3 papers)Epigenomics (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Hao Bo
65 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 982
- Molecular Biology 1.0k
- Oncology 206
- Reproductive Medicine 57
- Immunology 124
Countries citing papers authored by Hao Bo
This map shows the geographic impact of Hao Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Bo more than expected).
Fields of papers citing papers by Hao Bo
This network shows the impact of papers produced by Hao Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Bo. The network helps show where Hao Bo may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Bo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 190 | |
| 2 | 2015 | 128 | |
| 3 | 2016 | 125 | |
| 4 | 2018 | 70 | |
| 5 | 2014 | 64 | |
| 6 | 2016 | 63 | |
| 7 | 2009 | 60 | |
| 8 | 2019 | 58 | |
| 9 | 2013 | 58 | |
| 10 | 2017 | 56 | |
| 11 | 2018 | 49 | |
| 12 | 2014 | 48 | |
| 13 | 2018 | 46 | |
| 14 | 2019 | 45 | |
| 15 | 2019 | 42 | |
| 16 | 2018 | 41 | |
| 17 | 2020 | 37 | |
| 18 | 2021 | 34 | |
| 19 | 2012 | 29 | |
| 20 | 2021 | 27 |
About Hao Bo
Hao Bo is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 67 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (17 papers), Circular RNAs in diseases (12 papers), MicroRNA in disease regulation (7 papers), Testicular diseases and treatments (6 papers), Sarcoma Diagnosis and Treatment (5 papers), RNA Research and Splicing (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (982 citations), Molecular Biology (1.0k citations), Oncology (206 citations), Reproductive Medicine (57 citations) and Immunology (124 citations). Hao Bo has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Zhaojian Gong, Guiyuan Li, Zhaoyang Zeng, Xiayu Li, Wei Xiong, Ming Zhou, Wenling Zhang, Bo Xiang, Liqing Fan and Ke Cao. Their work appears in journals such as Journal of Cancer, Oncogene, Frontiers in Endocrinology, Epigenomics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.